These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20157742)

  • 21. Streptozotocin diabetic mice display depressive-like behavior and alterations in the structure, neurotransmission and plasticity of medial prefrontal cortex interneurons.
    Castillo-Gómez E; Coviello S; Perez-Rando M; Curto Y; Carceller H; Salvador A; Nacher J
    Brain Res Bull; 2015 Jul; 116():45-56. PubMed ID: 26112471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic stress alters inhibitory networks in the medial prefrontal cortex of adult mice.
    Gilabert-Juan J; Castillo-Gomez E; Guirado R; Moltó MD; Nacher J
    Brain Struct Funct; 2013 Nov; 218(6):1591-605. PubMed ID: 23179864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatiotemporal development of spinal neuronal and glial populations in the Ts65Dn mouse model of Down syndrome.
    Aziz NM; Klein JA; Brady MR; Olmos-Serrano JL; Gallo V; Haydar TF
    J Neurodev Disord; 2019 Dec; 11(1):35. PubMed ID: 31839007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABAergic phenotype of periglomerular cells in the rodent olfactory bulb.
    Panzanelli P; Fritschy JM; Yanagawa Y; Obata K; Sassoè-Pognetto M
    J Comp Neurol; 2007 Jun; 502(6):990-1002. PubMed ID: 17444497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered synaptic marker abundance in the hippocampal stratum oriens of Ts65Dn mice is associated with exuberant expression of versican.
    Howell MD; Gottschall PE
    ASN Neuro; 2012 Feb; 4(1):. PubMed ID: 22225533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn.
    Pollonini G; Gao V; Rabe A; Palminiello S; Albertini G; Alberini CM
    Neuroscience; 2008 Sep; 156(1):99-106. PubMed ID: 18703118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early chronic fasudil treatment rescues hippocampal alterations in the Ts65Dn model for down syndrome.
    López-Hidalgo R; Ballestín R; Lorenzo L; Sánchez-Martí S; Blasco-Ibáñez JM; Crespo C; Nacher J; Varea E
    Neurochem Int; 2024 Mar; 174():105679. PubMed ID: 38309665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
    Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
    Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GABAergic hyperinnervation of dentate granule cells in the Ts65Dn mouse model of down syndrome: Exploring the role of App.
    Mojabi FS; Fahimi A; Moghadam S; Moghadam S; Windy McNerneny M; Ponnusamy R; Kleschevnikov A; Mobley WC; Salehi A
    Hippocampus; 2016 Dec; 26(12):1641-1654. PubMed ID: 27701794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling the impact of neuromorphological alterations in Down syndrome on fast neural oscillations.
    Clusella P; Manubens-Gil L; Garcia-Ojalvo J; Dierssen M
    PLoS Comput Biol; 2024 Jul; 20(7):e1012259. PubMed ID: 38968294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental excitatory-to-inhibitory GABA polarity switch is delayed in Ts65Dn mice, a genetic model of Down syndrome.
    Lysenko LV; Kim J; Madamba F; Tyrtyshnaia AA; Ruparelia A; Kleschevnikov AM
    Neurobiol Dis; 2018 Jul; 115():1-8. PubMed ID: 29550538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: effects of environmental enrichment.
    Dierssen M; Benavides-Piccione R; Martínez-Cué C; Estivill X; Flórez J; Elston GN; DeFelipe J
    Cereb Cortex; 2003 Jul; 13(7):758-64. PubMed ID: 12816891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Appearance of Dendritic Alterations in Neocortical Pyramidal Neurons of the Ts65Dn Model of Down Syndrome.
    Uguagliati B; Stagni F; Emili M; Giacomini A; Russo C; Guidi S; Bartesaghi R
    Dev Neurosci; 2022; 44(1):23-38. PubMed ID: 34852343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteolytic degradation of glutamate decarboxylase mediates disinhibition of hippocampal CA3 pyramidal cells in cathepsin D-deficient mice.
    Shimizu T; Hayashi Y; Yamasaki R; Yamada J; Zhang J; Ukai K; Koike M; Mine K; von Figura K; Peters C; Saftig P; Fukuda T; Uchiyama Y; Nakanishi H
    J Neurochem; 2005 Aug; 94(3):680-90. PubMed ID: 15992379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced Dendritic Inhibition and Impaired NMDAR Activation in a Mouse Model of Down Syndrome.
    Schulz JM; Knoflach F; Hernandez MC; Bischofberger J
    J Neurosci; 2019 Jun; 39(26):5210-5221. PubMed ID: 31000585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Uguagliati B; Bonasoni MP; Bartesaghi R; Guidi S
    Brain Pathol; 2019 May; 29(3):366-379. PubMed ID: 30325080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic fluoxetine treatment alters the structure, connectivity and plasticity of cortical interneurons.
    Guirado R; Perez-Rando M; Sanchez-Matarredona D; Castrén E; Nacher J
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1635-46. PubMed ID: 24786752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice.
    Contestabile A; Fila T; Ceccarelli C; Bonasoni P; Bonapace L; Santini D; Bartesaghi R; Ciani E
    Hippocampus; 2007; 17(8):665-78. PubMed ID: 17546680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
    Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome.
    Belichenko NP; Belichenko PV; Kleschevnikov AM; Salehi A; Reeves RH; Mobley WC
    J Neurosci; 2009 May; 29(18):5938-48. PubMed ID: 19420260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.